MYR 0.5
(1.02%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 55.77 Million | 44.16 Million | -73.52 Million | 74.26 Million | -33.44 Million | -59.07 Million |
Net Income | 33.23 Million | 33.69 Million | 18.99 Million | 7.49 Million | 8.14 Million | 7.65 Million |
Depreciation & Amortization | 21.54 Million | 8.08 Million | 7.61 Million | 5.24 Million | 3.37 Million | 2.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -3.76 Million | -3.76 Million | -103.88 Million | 67.78 Million | -38.73 Million | -60.79 Million |
Other non-cash items | 63.6 Million | 6.14 Million | 3.74 Million | -6.26 Million | -6.23 Million | -8.83 Million |
Investing Cash Flow | -208.42 Million | -281.24 Million | -179.03 Million | -128.48 Million | -3.36 Million | 5.87 Million |
Investments in PPE | -208.58 Million | -282.12 Million | -181.44 Million | -98.31 Million | -11.57 Million | -26.39 Million |
Acquisitions | 23.99 Thousand | 30 Thousand | -1.69 Million | -38.45 Million | 926.32 Thousand | 32.47 Million |
Investment purchases | - | - | -14.65 Thousand | - | -4.25 Million | -2.76 Million |
Sales/Maturities of investments | 135 Thousand | 37.31 Thousand | 666.43 Thousand | 7.57 Million | 2.42 Million | 2.31 Million |
Other Investing Activities | 135 Thousand | 806.1 Thousand | 3.44 Million | 709.19 Thousand | 9.11 Million | 233.75 Thousand |
Financing Cash Flow | 278.78 Million | 198 Million | 241.58 Million | 65.23 Million | 43.72 Million | 5.49 Million |
Debt repayment | -286.75 Million | -225.34 Million | -130.82 Million | -135.57 Million | -1.63 Million | -380.23 Thousand |
Dividends payments | - | - | -3.08 Million | - | -5.4 Million | - |
Common Stock Repurchased | - | - | 316.49 Million | -2.71 Million | -662.29 Thousand | -1.92 Million |
Common Stock Issuance | 780 Thousand | - | 82.19 Million | 13.01 Million | 34.22 Million | - |
Other Financing Activities | -2.2 Million | 423.34 Million | -23.2 Million | 392.77 Million | 17.19 Million | 7.8 Million |
Accounts receivables | 21.81 Million | 32.08 Million | -47.63 Million | 15.06 Million | -27.97 Million | 29.78 Million |
Accounts payables | 61.22 Million | -22.29 Million | 25.61 Million | 40.06 Million | -22.22 Million | -47.52 Million |
Inventory | -98.79 Million | -44.22 Million | -30.35 Million | 6.98 Million | 24.74 Million | -18.69 Million |
Other working capital | 11.98 Million | 30.66 Million | -51.51 Million | 5.67 Million | -13.28 Million | -42.1 Million |
Cash at beginning of period | 33.04 Million | 41.18 Million | 52.19 Million | 41.19 Million | 34.48 Million | 84.06 Million |
Cash at end of period | 146.46 Million | 2.11 Million | 41.18 Million | 52.19 Million | 41.4 Million | 36.34 Million |
Capital Expenditure | -208.58 Million | -282.12 Million | -181.44 Million | -98.31 Million | -11.57 Million | -26.39 Million |
Effect of forex changes on cash | 35.74 Thousand | 15.14 Thousand | -25.87 Thousand | -20.64 Thousand | -1703.00 | 91.00 |
Net cash flow / Change in cash | 113.41 Million | -39.07 Million | -11.01 Million | 10.99 Million | 6.91 Million | -47.71 Million |
Free Cash Flow | -152.8 Million | -237.96 Million | -254.97 Million | -24.04 Million | -45.01 Million | -85.47 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 10.62 Million | 5.87 Million | 33.23 Million | 14.37 Million | 14.83 Million | 8.81 Million |
Depreciation & Amortization | - | - | 21.54 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -33.18 Million | -163.64 Million | -3.76 Million | 121.42 Million | -27.52 Million | -50.79 Million |
Other non-cash items | 3.04 Million | 15.42 Million | 63.6 Million | -36.85 Million | 9.38 Million | 7.4 Million |
Investing Cash Flow | -916 Thousand | 600 Thousand | -208.42 Million | -168.66 Million | -38.88 Million | -120 Thousand |
Investments in PPE | -916 Thousand | -523 Thousand | -208.58 Million | -168.82 Million | -38.98 Million | -218 Thousand |
Acquisitions | - | 760 Thousand | 23.99 Thousand | 23.99 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 135 Thousand | 135 Thousand | - | - |
Other Investing Activities | 113 Thousand | - | 135 Thousand | - | 95 Thousand | 98 Thousand |
Financing Cash Flow | 63.19 Million | 40.04 Million | 278.78 Million | 129.03 Million | 51.55 Million | 35.8 Million |
Debt repayment | -35.78 Million | -48.35 Million | -286.75 Million | -96.51 Million | -57.85 Million | -42.59 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 31.49 Million | - | 780 Thousand | - | 780 Thousand | - |
Other Financing Activities | -4.08 Million | 1000.00 | -2.2 Million | -2.2 Million | 108.62 Million | 78.4 Million |
Accounts receivables | - | - | 21.81 Million | - | - | - |
Accounts payables | 11.41 Million | -67.9 Million | 61.22 Million | 43.36 Million | 9.12 Million | 4.87 Million |
Inventory | - | - | -98.79 Million | - | - | - |
Other working capital | -44.59 Million | -95.74 Million | 11.98 Million | 155.03 Million | -36.65 Million | -55.67 Million |
Cash at beginning of period | 35.03 Million | 155.65 Million | 33.04 Million | 60.25 Million | 51.25 Million | 50.14 Million |
Cash at end of period | 90.31 Million | 45.34 Million | 146.46 Million | 146.46 Million | 60.62 Million | 51.25 Million |
Capital Expenditure | -916 Thousand | -523 Thousand | -208.58 Million | -168.82 Million | -38.98 Million | -218 Thousand |
Effect of forex changes on cash | - | - | 35.74 Thousand | -8.73 Million | - | - |
Net cash flow / Change in cash | 55.27 Million | -110.31 Million | 113.41 Million | 86.2 Million | 9.36 Million | 1.11 Million |
Free Cash Flow | -9 Million | -151.48 Million | -152.8 Million | -26.51 Million | -42.28 Million | -34.79 Million |
WTRNF
2301
D5IU
BLGVF
HOKCF
000500